FDA approved outpatient Exercise ECG telemetry solutions using dry electrode based wearable design, mobile App and cloud based portal
Funded by founders and angels from the US, India, Dubai, Singapore and Co-Creation Capital, NimbleHeart has built an FDA-approved, proprietary, Internet-connected, wireless ECG medical device and platform to enable both real-time and post-session cardiac monitoring and analysis. Its team has multidisciplinary skills including mechanical design, electrical design, mobile software development, signal processing algorithm design along with quality assurance and testing down to hands-on technical details. NimbleHeart’s mission is to provide clinical-level cardiac monitoring for the "at- risk" population in the comfort of their homes.NimbleHeart's FDA approved product is a prewsription product that is sold to cardiac rehab programs and wellness providers for primary and secondary cardiac preventive care.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 2, 2015 | Seed | $500K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
AngelList Talent | — | Seed |